Targeted Hypoglossal Neurostimulation Study #3 (THN3)
Research payments
$181,493
Through program year 2021, $181,493 in research payments was reported against Targeted Hypoglossal Neurostimulation Study #3 (THN3), across 97 payments, paid by LivaNova USA, Inc..
- Paid by
- LivaNova USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $30,429 | 44 |
| 2020 | Research | $151,064 | 53 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Winslow Louisville, KY Named on 14 payments
- Tod Huntley Carmel, IN Named on 11 payments
- Alan Schwartz Baltimore, MD Named on 10 payments
- Vseolod Polotsky Baltimore, MD Named on 10 payments
- Mitchell Miller Clearwater, FL Named on 9 payments
- Samuel Mickelson Atlanta, GA Named on 8 payments
- Martin Hopp Los Angeles, CA Named on 7 payments
- Ofer Jacobowitz Tarrytown, NY Named on 6 payments
- Marion Gillespie Memphis, TN Named on 5 payments
- Brian Weeks San Diego, CA Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.